Top Ranked Momentum Stocks to Buy for October 13th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 13th:
Alkermesplc ALKS: This biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.
Alkermes plc Price and Consensus
Alkermes plc price-consensus-chart | Alkermes plc Quote
Alkermes’ shares gained 3.2% over the last one month compared with the S&P 500’s decline of -1.9%. The company possesses a Momentum Score of A.
Alkermes plc Price
Alkermes plc price | Alkermes plc Quote
BPp.l.c. BP: This company that engages in exploration and production of crude oil and natural gas has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.7% over the last 60 days.
BP p.l.c. Price and Consensus
BP p.l.c. price-consensus-chart | BP p.l.c. Quote
BP’s shares gained 18% over the last one month. The company possesses a Momentum Score of A.
BP p.l.c. Price
BP p.l.c. price | BP p.l.c. Quote
Eni S.p.A. E: This company that engages in exploration, development, and production of crude oil and natural gas has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.8% over the last 60 days.
Eni SpA Price and Consensus
Eni SpA price-consensus-chart | Eni SpA Quote
Eni’s shares gained 10.3% over the last one month. The company possesses a Momentum Score of A.
Eni SpA Price
Eni SpA price | Eni SpA Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BP p.l.c. (BP) : Free Stock Analysis Report
Alkermes plc (ALKS) : Free Stock Analysis Report
Eni SpA (E) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research